FT-IR measurement of mercaptoundecahydrododecaborate (cas 12294-22-3) in human plasma
-
Add time:08/12/2019 Source:sciencedirect.com
A simple and rapid method for the quantitative measurement of mercaptoundecahydrododecarborate (BSH), (which presently is one of the most useful agents for Boron Neutron Capture Therapy) in human plasma was developed by using Fourier transform infrared spectroscopy. Different spacer thicknesses of the liquid sampling cell were examined and the optimal results were obtained by the 0.05 mm spacer. The subtraction of water absorbance from sample spectra resolved a B—H band at 2493 cm−1. The quantitative measurement of BSH was carried out by integration of the B—H band in the wavenumber range of 2534-2440 cm−1. However, at the lower BSH concentration range, a visual inspection of the spectrum to determine the wavenumber range was necessary so as to avoid any negative areas to be integrated. The lower limit of detection of BSH in aqueous solution and human plasma was 5 μg ml−1 (about 2.5 ppm of boron).
We also recommend Trading Suppliers and Manufacturers of mercaptoundecahydrododecaborate (cas 12294-22-3). Pls Click Website Link as below: cas 12294-22-3 suppliers
Prev:New functionalized mercaptoundecahydrododecaborate (cas 12294-22-3) derivatives for potential application in boron neutron capture therapy: Synthesis, characterization and dynamic visualization in cells
Next:High-performance liquid chromatographic assay for sodium mercaptoundecahydrododecaborate (cas 12294-22-3) in rat tissues) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (cas 12294-22-3) (BSH) fused cell-penetrating peptide08/16/2019
- Intracellular targeting of sodium mercaptoundecahydrododecaborate (cas 12294-22-3) (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT)08/15/2019
- Liquid chromatographic determination of sodium mercaptoundecahydrododecaborate (cas 12294-22-3) in rat urine and plasma after precolumn derivatization08/14/2019
- High-performance liquid chromatographic assay for sodium mercaptoundecahydrododecaborate (cas 12294-22-3) in rat tissues08/13/2019
- New functionalized mercaptoundecahydrododecaborate (cas 12294-22-3) derivatives for potential application in boron neutron capture therapy: Synthesis, characterization and dynamic visualization in cells08/11/2019
- Quantitation of sodium mercaptoundecahydrododecaborate (cas 12294-22-3) by capillary isotachophoresis08/10/2019
- Interaction of mercaptoundecahydrododecaborate (cas 12294-22-3) (BSH) with phosphatidylcholine: relevance to boron neutron capture therapy08/09/2019


